GlobeNewswire by notified

ZetaDisplay tecknar tilläggskontrakt med Swedish Match

Dela

Malmö ZetaDisplay AB (publ) (Nasdaq Stockholm:ZETA) har tecknat ett tilläggskontrakt inom befintligt ramavtal med Swedish Match. Företaget har varit kund sedan 2015 och avtalet omfattar skärminstallationer under de kommande fem månaderna. Installationerna gäller Swedish Matchs butiksnätverk i Sverige vilket består av shop-in-shop lösningar och flaggskeppsbutiker. Hårdvaruordervärdet uppskattas till 3,8 MSEK som kompletteras med tillkommande årliga SaaS-intäkter om 0,6 MSEK.

"Vi är mycket glada över det fortsatta förtroendet från Swedish Match. Vi kommer att leverera ny funktionalitet och avancerade mjukvaruintegrationer vilka är baserade på vår egen CMS-plattform. Digital kommunikation vid beslutsögonblicket har blivit ännu viktigare för dagens detaljhandelsmiljö. Vi är mycket glada över att kunna samarbeta med Swedish Match för att underlätta ett meningsfullt möte med konsumenten i beslutsögonblicket som drivs av kraften i Digital Signage-lösningen", kommenterar VD Per Mandorf.

Om Swedish Match

Swedish Match är ett globalt företag med marknadsledande varumärken inom tobak och icke-tobaksprodukter för vuxna konsumentupplevelser, samt tändstickor och tändare.  Några av dessa välkända varumärken är General, Longhorn, ZYN, Game, Red Man, Fiat Lux och Cricket. Försäljningen är koncentrerad till Norden, övriga Europa och USA, samt vissa andra marknader.

Malmö, 6 maj 2021

För vidare information, vänligen kontakta:

Per Mandorf, Koncernchef & VD
Telefon +46 704-25 82 34
Emailper.mandorf@zetadisplay.com

Jacob Stjernfält, CFO
Telefon +46 768- 754177
E-mailjacob.stjernfalt@zetadisplay.com

Daniel Oelker, CCO
Telefon +46 708-45 80 54
E-maildaniel.oelker@zetadisplay.com

Om ZetaDisplay

ZetaDisplay driver den digitala transformeringen i fysiska miljöer. Våra koncept och vår mjukvara påverkar människors beteende vid beslutstillfället i butiks- och offentliga miljöer samt arbetsplatser. Våra lösningar är kända som Digital Signage som vi utvecklar och erbjuder som SaaS-lösningar. ZetaDisplay är en europeisk ledare och kommer att driva den fortsatta konsolideringen av marknaden organiskt och genom förvärv.

ZetaDisplay har sitt säte i Malmö, omsätter cirka 450 Mkr och sysselsätter 200 medarbetare vid tio kontor i sex europeiska länder och USA. Totalt hanterar bolaget över 70 000 installationer på mer än 50 marknader. Aktien är noterad på Stockholmsbörsen Nasdaq [ZETA]. Mer information på www.ir.zetadisplay.com

Bilaga

För att se det här innehållet från www.globenewswire.com måste du ge ditt medgivande sidans topp.
För att se det här innehållet från ml-eu.globenewswire.com måste du ge ditt medgivande sidans topp.

Om

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Följ GlobeNewswire by notified

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire by notified

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares24.4.2024 03:36:40 CEST | Press release

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced the pricing of an underwritten public offering of 10,810,810 American Depositary Shares (“ADSs”), each representing one ordinary share, at a price to the public of $9.25 per ADS. The aggregate gross proceeds to Centessa from this offering are expected to be approximately $100 million, before deducting underwriting discounts and commissions and offering expenses payable by Centessa. All ADSs sold in the offering were offered by Centessa. The offering is expected to close on or about April 26, 2024, subject to customary closing conditions. Centessa has also granted the underwriters a 30-day option to purchase up to an additional 1,621,621 ADSs at the public offering price, less underwriting discounts and commissions. Goldman Sachs, Leerink Partners, Eve

UK businesses must prioritise payment technology to build customer loyalty and stay competitive: New research from Lloyds Bank and FreedomPay24.4.2024 01:01:00 CEST | Press release

London, United Kingdom, April 23, 2024 (GLOBE NEWSWIRE) -- Less than a third (27%) of businesses are confident they offer seamless payments experiences.Almost two-thirds of businesses (59%) across Retail, Food & Beverages and Hospitality believe a good checkout experience offers the same competitive advantage as having the best products.Customer preference is the factor most likely to influence businesses’ investment in payment technologies. New research from Lloyds Bank and FreedomPay highlights the importance of UK businesses investing in new payment technology. Two-thirds (59%) of UK Retail, Food & Beverage (F&B) and Hospitality companies were found to already put payments at the heart of their customer experience strategy, reflecting the growing importance of payment options to customers. For retail-focused businesses, 59% believe that a good checkout experience is essential to building customer loyalty, with respondents believing it is as much a competitive advantage as having the

Millicom announces the re-issuance of its AGM and EGM Convening Notice23.4.2024 22:30:00 CEST | Press release

Millicom announces the re-issuance of its AGM and EGM Convening Notice Luxembourg, April 23, 2024 – Millicom today announced the re-issuance of the Convening Notice to its Annual General Meeting (“AGM”) and Extraordinary General Meeting (“EGM”) of Shareholders which will be held on May 23, 2024. The Convening Notice contains a rectified note to the AGM agenda item 20 (Share Repurchase Plan). All other items of the AGM and EGM remain unchanged. The Convening Notice is appended to this press release and available on the company’s website at: https://www.millicom.com/our-company/corporate-governance/shareholder-meetings/. AGM voting materials have been updated to reflect the rectified note. -END- For further information, please contact AGM/EGM Inquiries: Patrick Gill, Company Secretary +352 27 759 603 Maria Florencia Maiori, Senior Legal Counsel information@millicom.comPress: Sofia Corral, Director Corporate Communications press@millicom.comInvestors: Michel Morin, VP Investor Relations i

CNH announces signing of a €3.25 billion committed revolving credit facility23.4.2024 22:30:00 CEST | Press release

CNH announces signing of a €3.25 billion committed revolving credit facility Basildon, April 23, 2024 On April 19, 2024, CNH (NYSE: CNHI) signed a €3.25 billion committed revolving credit facility, intended for general corporate purposes of the Company. The facility, entered into with a group of 18 banks providing aggregate commitments in excess of €3.5 billion, has a 5-year tenor with two extension options of one year each, exercisable on the first and second anniversary of the signing date. It replaces an existing 5-year €4 billion facility due to mature in March 2026. The final size of the facility, set at €3.25 billion, aligns with reduced funding needs following the demerger of Iveco Group. The transaction confirms the strong support of a large panel of international key relationship banks for the Company. CNH Industrial (NYSE: CNHI) is a world-class equipment and services company. Driven by its purpose of Breaking New Ground, which centers on Innovation, Sustainability and Produc

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares23.4.2024 22:17:37 CEST | Press release

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that it has commenced an underwritten public offering of $100 million of American Depositary Shares (“ADSs”), each representing one ordinary share. All of the ADSs are being offered by Centessa. In addition, Centessa intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of ADSs offered in the public offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Goldman Sachs and Leerink Partners are acting as lead joint book-running managers for the proposed offering. Evercore ISI, Guggenheim Securities and BMO Capital Markets are also acting as joint book-running mana

HiddenA line styled icon from Orion Icon Library.Eye